54 completed, 19 unknown, 4 terminated, 1 recruiting. 31 Phase 3, 24 Phase 2, 23 Phase 1, 5 Phase 4, 4 Not applicable.
Follow Green Cross Corporation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination MG1111 (BARICELA), VARIVAX, Suduvax - Varicella | Phase 2 | Recruiting | Green Cross Corporation | 230 | 2022-07-05 | 2024-01-24 |
| A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 GC1109 or Placebo of GC1109 - Anthrax | Phase 2 | Completed | Green Cross Corporation | 240 | 2021-07-14 | 2023-01-04 |
| A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer FOLFIRINOX - Urachal Cancer | Phase 2 | Unknown | Asan Medical Center | 35 | 2020-12-01 | 2020-11-02 |
| COVIDIG (COVID-19 Hyper-ImmunoGlobulin) GC5131, Placebo - Covid19 | Phase 2 | Completed | Green Cross Corporation | 63 | 2020-09-19 | 2021-08-24 |
| Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis: Immunoglobulin G - Autoimmune Encephalitis | Phase 2 | Completed | Green Cross Corporation | 23 | 2019-11-20 | 2020-06-30 |
| A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults GC3111 vaccine, Boostrix® vaccine - Tetanus, Diphtheria | Phase 2 | Unknown | Green Cross Corporation | 213 | 2019-10-14 | 2020-01-23 |
| A Study of GC3107(BCG Vaccine) in Healthy Infants GC3107, Intradermal BCG SSI inj. - BCG Vaccination Reaction, Tuberculosis | Phase 3 | Completed | Green Cross Corporation | 750 | 2019-08-06 | 2022-11-02 |
| Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency Immunoglobulin - Primary Immune Deficiency Disorder | Phase 3 | Withdrawn | Green Cross Corporation | 2019-04-30 | 2020-07-07 | |
| A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients GC1102, GC1102 Placebo - Hepatitis B | Phase 2 | Unknown | Green Cross Corporation | 42 | 2019-02-11 | 2019-12-13 |
| Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease Immunoglobulin G, Acetylsalicylic acid - Kawasaki Disease | Phase 4 | Completed | Green Cross Corporation | 45 | 2019-02-01 | 2020-05-21 |
| A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients MG1113, Placebo of MG1113 - Hemophilia | Phase 1 | Completed | Green Cross Corporation | 41 | 2019-01-21 | 2021-10-26 |
| Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects CRV 101, Placebo - Herpes Zoster, Varicella Zoster | Phase 1 | Completed | Curevo Inc | 90 | 2019-01-03 | 2021-02-11 |
| A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects GC3114, GCFLU Quadrivalent - Influenza, Human | Phase 2 | Completed | Green Cross Corporation | 105 | 2018-10-01 | 2019-01-04 |
| Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor Influenza vaccination - Influenza, Solid Carcinoma | Not applicable | Completed | Seoul National University Hospital | 143 | 2018-09-01 | 2019-09-19 |
| Effect of Polyglycolic Acid Mesh (Neoveil) in Thyroid Cancer Surgery Neoveil (Polyglycolic Acid Mesh) - Thyroid Gland Carcinoma, Thyroid Cancer | Not applicable | Unknown | Seoul National University Hospital | 330 | 2018-05-01 | 2018-04-27 |
| A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy irinotecan, FOLFIRI - Metastatic Colorectal Cancer, Solid Tumor | Phase 1 / Phase 2 | Completed | Green Cross Corporation | 53 | 2018-04-02 | 2022-03-03 |
| HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102 GC1102 80,000 IU, GC1102 100,000 IU, I.V HBIG - Hepatitis B Infection | Phase 2 / Phase 3 | Unknown | Green Cross Corporation | 186 | 2018-03-29 | 2020-01-30 |
| Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults GC3107 - Tuberculosis | Phase 1 | Unknown | Green Cross Corporation | 20 | 2017-12-14 | 2017-12-18 |
| A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults GC3114, GCFLU Quadrivalent - Influenza, Human | Phase 1 | Completed | Green Cross Corporation | 40 | 2017-11-20 | 2018-11-19 |
| A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age GC3110A, GCFLU Pre-filled syringe inj. - Influenza Vaccine | Phase 3 | Unknown | Green Cross Corporation | 260 | 2017-09-30 | 2017-09-18 |
Showing 20 of 79. Sign in to see all of them.
Influenza, Human (16) · Mucopolysaccharidosis II (5) · Hemophilia A (4) · Hepatitis B (4) · Osteoarthritis (4) · Hepatitis B, Chronic (3) · Anthrax (2) · Bacterial Infections (2) · Chickenpox (2) · Colorectal Neoplasms (2) · Diphtheria (2) · Immunologic Deficiency Syndromes (2) · Influenza in Birds (2) · Mucocutaneous Lymph Node Syndrome (2) · Primary Immunodeficiency Diseases (2)
Immunoglobulin G (4) · Chickenpox Vaccine (3) · Influenza Vaccines (3) · Sodium Chloride (3) · shinbaro (3) · Boostrix (2) · Fluid Therapy (2) · Saline Solution (2) · Vaccination (2) · gamma-Globulins (2) · pegfilgrastim (2) · Amoxicillin (1) · Aspirin (1) · Bismuth (1) · Celecoxib (1)
South Korea (59) · United States (8) · Canada (3) · New Zealand (1) · Poland (1) · Russia (1) · Ukraine (1) · United Kingdom (1) · Vietnam (1)
Chang-Hee Lee, M.D. (2) · Choi Won Seck, M.D (2) · Dong-Kyu Jin (2) · Jeong Suk In (2) · Kim Sin Woo (2) · Kim Tae Hyung (2) · Lee Ja Cob (2) · Lee Jin Su, M.D (2) · Wi Sung Heon (2) · Woo Heong Jung (2) · Woo Joo KIm, M.D, Ph.D (2) · Woo Joo Kim, MD, Ph.D (2) · BG Lee (1) · Chaim Roifman (1) · Chaim Roifman, MD (1)
PMID 18495536, PMID 23497636, PMID 25860987, PMID 26597705, PMID 27196293, PMID 27449412, PMID 27460100, PMID 27784046, PMID 28119295, PMID 29573247, PMID 29736158, PMID 30686952, PMID 31164456, PMID 31377075, PMID 31680143, PMID 33131933, PMID 33736920, PMID 34010932, PMID 34305948